Live Breaking News & Updates on Immune And Biological Products

Stay updated with breaking news from Immune and biological products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chumakov Center plans to double CoviVac production in October, says director general

Chumakov Center plans to double CoviVac production in October, says director general
tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.

Stavropol Skiy Kray , Aidar Ishmukhametov , Chumakov Federal Scientific Center , Gamaleya Scientific Research Institute Of Epidemiology , Chumakov Center , Research Center , Russian Health Ministry On , Russian Academy Of Science Chumakov Center , Director General Aidar Ishmukhametov , Immune And Biological Products , Russian Academy , Russian Health Ministry , Sputnik Light , Gamaleya Scientific Research Institute , Biotechnology Vector , Science Chumakov ,

Russian Chumakov Center discusses CoviVac vaccine's approval in Asia and US - Society & Culture

Russian Chumakov Center discusses CoviVac vaccine's approval in Asia and US - Society & Culture
tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.

United States , South Korea , Aidar Ishmukhametov , Mikhail Chumakov , Development Of Products , Russian Academy Of Sciences , Chumakov Federal Scientific Center , Korean Ministry Of Food , Academy Of Medical Sciences , Russia Chumakov Federal Scientific Center , Chumakov Center , Institute Of Poliomyelitis , Southeast Asia , South America , Russian Academy , South Korean Ministry , Drug Safety , Immune And Biological Products , Viral Encephalitides , Soviet Academy , Academician Mikhail Chumakov , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , வளர்ச்சி ஆஃப் ப்ராடக்ட்ஸ் , ரஷ்ய கலைக்கழகம் ஆஃப் அறிவியல் , கொரியன் அமைச்சகம் ஆஃப் உணவு ,

ITMO: Understanding Vaccines: Types, Tests, and Choosing the Right One

ITMO: Understanding Vaccines: Types, Tests, and Choosing the Right One
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

Stavropol Skiy Kray , Anton Gopka , Vektor Center , Chumakov Federal Scientific Center , Immune And Biological Products , Russian Academy , Russian Epivaccorona , நோய் எதிர்ப்பு சக்தி மற்றும் உயிரியல் ப்ராடக்ட்ஸ் , ரஷ்ய கலைக்கழகம் ,

Vaccine producer says too early to tout CoviVac's efficacy

According to Chumakov Center Director General Aidar Ishmukhametov, CoviVac could be effective against all current coronavirus variants ....

Stavropol Skiy Kray , Sankt Peterburg , Aidar Ishmukhametov , Chumakov Federal Scientific Center , Petersburg International Economic Forum , Chumakov Center , Roscongress Foundation , Russian Health Ministry On , Phase Two , Petersburg International Economic , Immune And Biological Products , Russian Academy , Russian Health Ministry , Together Again , Healthy Life , Drug Security Forums , பீட்டர்ஸ்பர்க் சர்வதேச பொருளாதார மன்றம் , ரஷ்ய ஆரோக்கியம் அமைச்சகம் ஆன் , கட்டம் இரண்டு , பீட்டர்ஸ்பர்க் சர்வதேச பொருளாதார , நோய் எதிர்ப்பு சக்தி மற்றும் உயிரியல் ப்ராடக்ட்ஸ் , ரஷ்ய கலைக்கழகம் , ரஷ்ய ஆரோக்கியம் அமைச்சகம் , ஒன்றாக மறுபடியும் , ஆரோக்கியமான வாழ்க்கை ,

Russia's Chumakov Center plans to start Phase 3 trials of CoviVac vaccine in several weeks

25 May 2021 13:30
Russia s Chumakov Center plans to start Phase 3 trials of CoviVac vaccine in several weeks - general director
MOSCOW. May 25 (Interfax) - Phase 3 clinical trials of the Covid-19 whole-virion vaccine CoviVac may begin in a couple of weeks, according to Aidar Ishmukhametov, general director of the Russian Academy of Sciences Chumakov Federal Center for Research and Development of Immune-and-Biological Products, the vaccine s developer.
It is up to the Health Ministry to make this decision. We submitted [documents to start Phase 3 trials of the CoviVac vaccine], we were asked additional questions, as it usually happens, and we answered them. We are now awaiting its decision. I think that we will start Phase 3 trials of CoviVac in a week or two, Ishmukhametov said in an interview published in the Izvestia newspaper on Tuesday. ....

Stavropol Skiy Kray , Aidar Ishmukhametov , Russian Academy Of Science Chumakov Federal Center , Development Of Products , Chumakov Center Covivac , Gamaleya National Research Center , Russia Chumakov Center , Health Ministry , Rospotrebnadzor Vector State Research Center , Chumakov Center , Russian Academy , Science Chumakov Federal Center , Immune And Biological Products , Sputnik Light , Novosibirsk Based Vector State Research Center , வளர்ச்சி ஆஃப் ப்ராடக்ட்ஸ் , ஆரோக்கியம் அமைச்சகம் , ரஷ்ய கலைக்கழகம் , நோய் எதிர்ப்பு சக்தி மற்றும் உயிரியல் ப்ராடக்ட்ஸ் , ஸ்பட்நிக் ஒளி ,